Are you over 18 and want to see adult content?
More Annotations

Shrewsbury chief Sam Ricketts has sympathy with Liverpool boss Jurgen Klopp over FA Cup replay decision - Shropshire Star
Are you over 18 and want to see adult content?

Officiel, LeBron James devient le troisième meilleur marqueur de tous les temps - Kobe dans le rétro, l'histoire dans le viseu
Are you over 18 and want to see adult content?
Favourite Annotations

Symphony. An open source CMS.
Are you over 18 and want to see adult content?

Gelöschte Wikipedia Artikel im MARJORIE WIKI
Are you over 18 and want to see adult content?

UK`s Largest Woodland Conservation Charity - Woodland Trust
Are you over 18 and want to see adult content?

Visa - Leading Global Payment Solutions - Visa
Are you over 18 and want to see adult content?

Best Web Design Services - Best Web Design Company Pakistan
Are you over 18 and want to see adult content?

MOL Fehérvár FC hivatalos weboldala - Official website -... - molfehervarfc.hu
Are you over 18 and want to see adult content?

Home - The WOW Foundation
Are you over 18 and want to see adult content?

A complete backup of https://cogtiovidiropgold.tk
Are you over 18 and want to see adult content?

Emotional Support Animal Letter Service 74.95 Renewals
Are you over 18 and want to see adult content?

La Crónica de Salamanca - Periódico digital de Salamanca con todas las noticias y sucesos
Are you over 18 and want to see adult content?
Text
ZS ONCOLOGY
ZS Oncology. In the pharmaceutical and biotechnology industry, ZS is a leader in delivering actionable insights based on rigorous analytics. We use these insights to develop the right strategy, marketing, sales and operations plans to lead our clients to successful oncology product commercialization. ZS brings together multiple areas of expertise—therapeutic depth, qualitative marketSERVER LOGIN
Log in. Username:: Forgot Username: Password:: Forgot Password AMERICAS - ZS ASSOCIATES Why ZS and Anaplan. Many companies struggle with the ability to optimally plan and manage performance due to limitations in availabletechnologies.
AMERICAS - PAGES.ZSASSOCIATES.COM Tobi Laczkowski is a principal in ZS Associates’ Evanston, Ill., office and was previously based in the Zurich office. He has worked primarily with medical products clients in numerous practice areas, including sales force effectiveness, go-to-market strategy and transformation, compensation design, value proposition design and recruiting effectiveness. AMERICAS - PAGES.ZSASSOCIATES.COM ZS AccessMonitor TM: 53% of physicians now restrict access to pharma reps. According to the 2015 AccessMonitor TM report, which analyzes sales call data from more than 70 percent of U.S. pharmaceutical sales teams, more than half (53%) of physicians are now considered “access-restricted” for sales reps. Read the summary to learn why access-restrictions continue to grow and what you can ONCOLOGY VALUE WATCHDOG REPORT: INTRODUCTION TO VALUE IN Oncology Value Watchdog Report: Introduction to Value in Oncology: Definitions, Drivers, and Implication. The value of oncology drugs is of great interest to patients, physicians, payers and policymakers. CUTTING BIG DATA DOWN TO SIZE Cutting Big Data Down to Size. Big data has been embraced in a variety of verticals, but not all industries have implemented big datasolutions.
AMERICAS - PAGES.ZSASSOCIATES.COM There are a lot of moving parts when it comes to appropriately rewarding and incentivizing your sales force within the medtech industry. And when you’re trying to stay abreast of all of those moving parts—pay benchmarking, quota-setting, new hire plans, long-term incentive programs, President’s Club—it can be difficult to take a step back and spot potential issues before they turn into HOW CONFIDENT MEDTECH COMPANIES ARE BOOSTING INCENTIVES TO How Confident Medtech Companies are Boosting Incentives to Drive Growth. Medtech companies reported significant revenue increases in 2014 and are using incentive plans more assertively to continue and accelerate growth in 2015. AMERICAS - PAGES.ZSASSOCIATES.COM ZS Oncology Value Watchdog Report ASCO 2016: Spotlight on Value. At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives.ZS ONCOLOGY
ZS Oncology. In the pharmaceutical and biotechnology industry, ZS is a leader in delivering actionable insights based on rigorous analytics. We use these insights to develop the right strategy, marketing, sales and operations plans to lead our clients to successful oncology product commercialization. ZS brings together multiple areas of expertise—therapeutic depth, qualitative marketSERVER LOGIN
Log in. Username:: Forgot Username: Password:: Forgot Password AMERICAS - ZS ASSOCIATES Why ZS and Anaplan. Many companies struggle with the ability to optimally plan and manage performance due to limitations in availabletechnologies.
AMERICAS - PAGES.ZSASSOCIATES.COM Tobi Laczkowski is a principal in ZS Associates’ Evanston, Ill., office and was previously based in the Zurich office. He has worked primarily with medical products clients in numerous practice areas, including sales force effectiveness, go-to-market strategy and transformation, compensation design, value proposition design and recruiting effectiveness. AMERICAS - PAGES.ZSASSOCIATES.COM ZS AccessMonitor TM: 53% of physicians now restrict access to pharma reps. According to the 2015 AccessMonitor TM report, which analyzes sales call data from more than 70 percent of U.S. pharmaceutical sales teams, more than half (53%) of physicians are now considered “access-restricted” for sales reps. Read the summary to learn why access-restrictions continue to grow and what you can ONCOLOGY VALUE WATCHDOG REPORT: INTRODUCTION TO VALUE IN Oncology Value Watchdog Report: Introduction to Value in Oncology: Definitions, Drivers, and Implication. The value of oncology drugs is of great interest to patients, physicians, payers and policymakers. CUTTING BIG DATA DOWN TO SIZE Cutting Big Data Down to Size. Big data has been embraced in a variety of verticals, but not all industries have implemented big datasolutions.
AMERICAS - PAGES.ZSASSOCIATES.COM There are a lot of moving parts when it comes to appropriately rewarding and incentivizing your sales force within the medtech industry. And when you’re trying to stay abreast of all of those moving parts—pay benchmarking, quota-setting, new hire plans, long-term incentive programs, President’s Club—it can be difficult to take a step back and spot potential issues before they turn into HOW CONFIDENT MEDTECH COMPANIES ARE BOOSTING INCENTIVES TO How Confident Medtech Companies are Boosting Incentives to Drive Growth. Medtech companies reported significant revenue increases in 2014 and are using incentive plans more assertively to continue and accelerate growth in 2015. AMERICAS - PAGES.ZSASSOCIATES.COM ZS Oncology Value Watchdog Report ASCO 2016: Spotlight on Value. At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives. ANNUAL RECOGNITION PROGRAM QUOTA˜SETTING BEWARE: Only about 1/2 of medtech companies are actually using third-party data to develop their quotas. reported being somewhat or very satisfied withZS ONCOLOGY
ZS Oncology. In the pharmaceutical and biotechnology industry, ZS is a leader in delivering actionable insights based on rigorous analytics. We use these insights to develop the right strategy, marketing, sales and operations plans to lead our clients to successful oncology product commercialization. ZS brings together multiple areas of expertise—therapeutic depth, qualitative marketSERVER LOGIN
Log in. Username:: Forgot Username: Password:: Forgot Password AMERICAS - ZS ASSOCIATES Why ZS and Anaplan. Many companies struggle with the ability to optimally plan and manage performance due to limitations in availabletechnologies.
AMERICAS - PAGES.ZSASSOCIATES.COM ZS AccessMonitor TM: 53% of physicians now restrict access to pharma reps. According to the 2015 AccessMonitor TM report, which analyzes sales call data from more than 70 percent of U.S. pharmaceutical sales teams, more than half (53%) of physicians are now considered “access-restricted” for sales reps. Read the summary to learn why access-restrictions continue to grow and what you can AMERICAS - PAGES.ZSASSOCIATES.COM Tobi Laczkowski is a principal in ZS Associates’ Evanston, Ill., office and was previously based in the Zurich office. He has worked primarily with medical products clients in numerous practice areas, including sales force effectiveness, go-to-market strategy and transformation, compensation design, value proposition design and recruiting effectiveness. ONCOLOGY VALUE WATCHDOG REPORT: INTRODUCTION TO VALUE IN Oncology Value Watchdog Report: Introduction to Value in Oncology: Definitions, Drivers, and Implication. The value of oncology drugs is of great interest to patients, physicians, payers and policymakers. BUILDING A CUSTOMER-FOCUSED GROWTH ENGINE: ESTABLISHING The often-mentioned quote “Nothing happens until someone sells something” is a strong tribute to the importance of the sales organization.1 Even so, sales continues to be one of the most poorly understood and underoptimized areas of business. AMERICAS - PAGES.ZSASSOCIATES.COM There are a lot of moving parts when it comes to appropriately rewarding and incentivizing your sales force within the medtech industry. And when you’re trying to stay abreast of all of those moving parts—pay benchmarking, quota-setting, new hire plans, long-term incentive programs, President’s Club—it can be difficult to take a step back and spot potential issues before they turn into HOW CONFIDENT MEDTECH COMPANIES ARE BOOSTING INCENTIVES TO How Confident Medtech Companies are Boosting Incentives to Drive Growth. Medtech companies reported significant revenue increases in 2014 and are using incentive plans more assertively to continue and accelerate growth in 2015. AMERICAS - PAGES.ZSASSOCIATES.COM ZS Oncology Value Watchdog Report ASCO 2016: Spotlight on Value. At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives.ZS ONCOLOGY
ZS Oncology. In the pharmaceutical and biotechnology industry, ZS is a leader in delivering actionable insights based on rigorous analytics. We use these insights to develop the right strategy, marketing, sales and operations plans to lead our clients to successful oncology product commercialization. ZS brings together multiple areas of expertise—therapeutic depth, qualitative marketSERVER LOGIN
Log in. Username:: Forgot Username: Password:: Forgot Password AMERICAS - ZS ASSOCIATES Why ZS and Anaplan. Many companies struggle with the ability to optimally plan and manage performance due to limitations in availabletechnologies.
AMERICAS - PAGES.ZSASSOCIATES.COM ZS AccessMonitor TM: 53% of physicians now restrict access to pharma reps. According to the 2015 AccessMonitor TM report, which analyzes sales call data from more than 70 percent of U.S. pharmaceutical sales teams, more than half (53%) of physicians are now considered “access-restricted” for sales reps. Read the summary to learn why access-restrictions continue to grow and what you can AMERICAS - PAGES.ZSASSOCIATES.COM Tobi Laczkowski is a principal in ZS Associates’ Evanston, Ill., office and was previously based in the Zurich office. He has worked primarily with medical products clients in numerous practice areas, including sales force effectiveness, go-to-market strategy and transformation, compensation design, value proposition design and recruiting effectiveness. ONCOLOGY VALUE WATCHDOG REPORT: INTRODUCTION TO VALUE IN Oncology Value Watchdog Report: Introduction to Value in Oncology: Definitions, Drivers, and Implication. The value of oncology drugs is of great interest to patients, physicians, payers and policymakers. BUILDING A CUSTOMER-FOCUSED GROWTH ENGINE: ESTABLISHING The often-mentioned quote “Nothing happens until someone sells something” is a strong tribute to the importance of the sales organization.1 Even so, sales continues to be one of the most poorly understood and underoptimized areas of business. AMERICAS - PAGES.ZSASSOCIATES.COM There are a lot of moving parts when it comes to appropriately rewarding and incentivizing your sales force within the medtech industry. And when you’re trying to stay abreast of all of those moving parts—pay benchmarking, quota-setting, new hire plans, long-term incentive programs, President’s Club—it can be difficult to take a step back and spot potential issues before they turn into HOW CONFIDENT MEDTECH COMPANIES ARE BOOSTING INCENTIVES TO How Confident Medtech Companies are Boosting Incentives to Drive Growth. Medtech companies reported significant revenue increases in 2014 and are using incentive plans more assertively to continue and accelerate growth in 2015. AMERICAS - PAGES.ZSASSOCIATES.COM ZS Oncology Value Watchdog Report ASCO 2016: Spotlight on Value. At ASCO 2016, the physician community continued to be highly involved in discussions about value and value initiatives. ANNUAL RECOGNITION PROGRAM QUOTA˜SETTING BEWARE: Only about 1/2 of medtech companies are actually using third-party data to develop their quotas. reported being somewhat or very satisfied with*
Insights
INSIGHTS
Expertise and perspectives to create impact that matters.See overview
All Insights
Impact Series
Live, on-demand events and podcastsLife at ZS
Stories of ZS's people*
Industries
INDUSTRIES
From healthcare to high-tech, our deep domain expertise ensures that solutions work for you.See overview
Pharmaceuticals & Biotech Analytics, technology and strategyMedical Technology
Product launches, pricing, contractingHealth Plans
Solutions to shift to value-based careFinancial Services
Data-driven go-to-market strategies High-Tech & Telecommunications Sales and marketing solutions Industrials & Business Services Strategies and go-to-market modelsPrivate Equity
Driving market growth Travel & Hospitality Commercial function optimization*
Solutions
SOLUTIONS
It’s about results, not just ideas. We deliver solutions that workin the real world.
See overview
Strategy & Advisory
Strategy & Advisory Overview Strategy & TransformationCustomer Experience
AI & Analytics
AI & Analytics OverviewAnalytics
Artificial Intelligence Technology & Operations Technology & Operations Overview Strategy & Architecture Enterprise Data ManagementAnalytics Platforms
Application Development & ManagementManaged Services
Process Excellence & Automation Life Sciences R&D & Medical Life Sciences R&D & Medical Overview Clinical DevelopmentMedical Affairs
Value & Access
Value & Access OverviewValue Strategy
Pricing Strategy
Real-World Evidence
Access Strategy & Implementation Portfolio & Pipeline Portfolio & Pipeline Overview Portfolio Strategy & Management Pipeline Asset StrategyLaunch
Business Development & LicensingForecasting
Revenue Management
Marketing
Marketing Overview
Customer Insights
Marketing Strategy
Brand & Messaging
Promotions & Marketing MixSales
Sales Overview
Commercial Model Design & Operations Key Account ManagementSales Compensation
Sales Effectiveness
Channel Management
*
Products
PRODUCTS
Our software products enable your success with leading-edge analytics and domain expertise.See overview
JAVELIN
Sales strategy management platformREVO
Integrated analytics platformVERSO
Intelligent execution softwareSoftware Support
Dedicated technical support*
Who We Are
WHO WE ARE
With ZS, you have a partner committed to getting it right the firsttime.
Our Story
Committed to getting it rightOur Impact
Creating real-world solutionsOur People
A team with experience and vision Inclusion & Diversity Our beliefs and commitmentOffices
Our global network
News & Events
What’s happening at ZSAwards & Accolades
Recognition of ZS’s work and culturePartnerships
Our premier partner network*
Join ZS
JOIN ZS
Our people are our most valuable asset.ZS Careers
Find your fit
Life at ZS
Our people and culture Campus Beats—India Campus engagement programInterviewing
Our process
Students
Internships and recent graduates*
REGIONS
Asia
India
Japan
Singapore
Europe
Latin America
North America
Canada
Contact us
AI & ANALYTICS
IS AI A RACE TO BE WON? Read moreOpens in a new tab*
* VBC Innovation
* Forbes Feature
* RWE Outlook Report FEATURED NEWS AND INSIGHTSSee more insights
HEALTH PLANS
HOW VALUE-BASED CARE CAN SUPPORT THE GROWING MENTAL AND BEHAVIORALHEALTH NEED
May 24, 2021 | Article TECHNOLOGY & OPERATIONS AMGEN Q&A: DRIVING DIGITAL HEALTH INNOVATION IN PHARMA April 30, 2021 | Q&A LIFE SCIENCES R&D & MEDICAL REAL-WORLD DATA AND EVIDENCE INDUSTRY OUTLOOK REPORT April 29, 2021 | White PaperSee more insights
WHO WE ARE
WE’RE PASSIONATELY COMMITTED TO HELPING OUR CLIENTS AND THEIR CUSTOMERS THRIVE, WORKING SIDE BY SIDE TO DRIVE CUSTOMER VALUE ANDRESULTS
Learn more about us
CURATED CAROUSEL
OUR IMPACT
ASTELLAS PHARMA EUROPE LIMITED DELIVERS AI-ENABLED INSIGHTS IN A USER-FRIENDLY PACKAGE With ZS's VERSO™, APEL improved data usability and empowered its commercial teams to create stronger customer engagement strategies.Read the case study
*
*
*
*
FEATURED INDUSTRIES
DEEP EXPERTISE ACROSS INDUSTRIESSee all industries
PHARMACEUTICALS & BIOTECH Solve complex challenges across the research, discovery and commercialization life cycle.Learn more
MEDICAL TECHNOLOGY
Improve commercial effectiveness and accelerate your revenue growth.Learn more
HIGH-TECH & TELECOMMUNICATIONS Identify, develop and deliver innovative sales and marketing solutions to drive competitive advantage.Learn more
See all industries
FEATURED SOLUTIONS
SOLUTIONS TO MEET YOUR NEEDSSee all solutions
STRATEGY & ADVISORY
From portfolio management and growth strategy to customer experience and digital transformation, we help clients improve performance and deliver lasting value. Learn moreSALES
Increase your commercial organization’s efficiency and effectiveness with smarter sales strategies, team structures and performance management solutions.Learn more TECHNOLOGY & OPERATIONS Tap into our broad suite of technology solutions—innovative strategy, scalable implementation and automated operations—to help your company thrive.Learn moreSee all solutions
CAREERS
JOIN OUR TEAM
Our people are our most valuable asset—a fact that's reflected in our values-driven organization in which new perspectives are integral and new ideas are celebrated.View open roles
LET’S GET STARTED
Contact us
ADD INSIGHTS TO YOUR INBOX Subscribe to ZS content Details about how we process your information are available in ourPrivacy Policy .
Terms of Use Privacy Policy Do Not Sell My Personal Information Linkedin profile (Opens in a new tab) Twitter profile (Opens in a new tab) Facebook profile (Opens in a new tab) Youtube profile (Opens in a new tab) Instagram profile (Opens in anew tab)
PRIVACY PREFERENCE CENTERYOUR PRIVACY
YOUR PRIVACY
Our Web sites use cookies and technologies which are similar to cookies. A cookie is a small piece of information that is sent to your browser and stored in your device’s memory. We use cookies to deliver services requested by you, as well as to improve the quality of our online services by storing user preferences and monitoring user trends. You can control how your browser handles cookies received from our Web site. You can choose to refuse all cookies, be prompted before a cookie is saved to your hard drive or device memory, or only accept cookies from certain Web sites that you designate. Information on deleting or controlling cookies is available at www.allaboutcookies.org. By refusing to accept cookies from us, you may not be able to use some of the features and functionality available on our Web site. More information*
STRICTLY NECESSARY COOKIES STRICTLY NECESSARY COOKIESAlways Active
Strictly Necessary Cookies These cookies are necessary for the Web site to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.Cookies details
*
PERFORMANCE COOKIES
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitorits performance.
Cookies details
*
FUNCTIONAL COOKIES
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the Web site to provide enhanced functionality and personalization. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.Cookies details
*
TARGETING COOKIES
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and device. If you do not allow these cookies, you will experience less targeted advertising.Cookies details
Back Button
ADVERTISING COOKIES
Filter Button
Consent Leg.InterestSelect All Vendors
Select All Vendors
Select All Hosts
Select All
*
REPLACE-WITH-DYANMIC-HOST-ID33ACROSS
33ACROSS
View Third Party Cookies*
Name
cookie name
*
REPLACE-WITH-DYANMIC-VENDOR-ID33ACROSS
3 Purposes
View Privacy Notice
33ACROSS
3 Purposes
View Privacy Notice
REPLACE-WITH-DYANMIC-VENDOR-IDConsent Purposes
Location Based Ads
Consent Allowed
Legitimate Interest PurposesPersonalize
Require Opt-Out
Special Purposes
Location Based Ads
Features
Location Based Ads
Special Features
Location Based Ads
Clear Filters
Information storage and accessApply Save settings Allow all This website uses cookies. To accept all cookies or adjust your cookie preferences, click the links to the right. Learn more Cookie settings Accept cookiesDetails
Copyright © 2023 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0